$BHAC
Focus Impact BH3 Acquisition Co Stock $bhac

$bhac Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000114036124021328 Filed on April 23, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$903.5K	$1.692M	$675.9K
YoY Change	33.68%	-20.27%
Operating Profit		-$1.692M
YoY Change		-179.73%
Interest Expense	-$202.5K	$3.259M	$1.878M
YoY Change	-110.78%	-67.0%	-113.05%
% of Operating Profit
Other Income/Expense, Net	$6.820M	$6.820M	$0.00
YoY Change			-100.0%
Pretax Income	$5.714M	$8.387M	$1.202M
YoY Change	375.42%	8.17%	-109.7%
Income Tax	-$379.3K	$510.3K	$86.23K
% Of Pretax Income	-6.64%	6.08%	7.17%
Net Earnings	$6.093M	$7.876M	$1.116M
YoY Change	446.16%	2.74%	-109.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.74	$0.78	$0.05
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$631.3K	$631.3K	$13.72K
YoY Change	4501.6%	4501.6%	-98.79%
Cash & Equivalents	$631.3K		$13.72K
Short-Term Investments
Other Short-Term Assets	$11.31K	$11.31K	$0.00
YoY Change			-100.0%
Inventory
Prepaid Expenses	$11.31K
Receivables
Other Receivables
Total Short-Term Assets	$780.9K	$780.9K	$13.72K
YoY Change	5593.91%	5591.84%	-99.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$24.55M	$24.55M	$51.34M
YoY Change	-52.17%	-52.17%	-77.9%
Other Assets
YoY Change
Total Long-Term Assets	$24.55M	$24.55M	$51.34M
YoY Change	-52.17%	-52.17%	-77.9%
TOTAL ASSETS
Total Short-Term Assets	$780.9K	$780.9K	$13.72K
Total Long-Term Assets	$24.55M	$24.55M	$51.34M
Total Assets	$25.34M	$25.34M	$51.35M
YoY Change	-50.66%	-50.66%	-78.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$157.8K	$157.8K	$88.01K
YoY Change	79.29%
Accrued Expenses	$1.240M	$1.240M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$300.0K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$64.75K	$64.75K
YoY Change
Total Short-Term Liabilities	$2.882M	$2.882M	$2.509M
YoY Change	14.88%	14.88%	-72.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$8.050M
YoY Change	-100.0%	-100.0%	0.0%
Total Long-Term Liabilities	$0.00	$0.00	$8.050M
YoY Change	-100.0%	-100.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.882M	$2.882M	$2.509M
Total Long-Term Liabilities	$0.00	$0.00	$8.050M
Total Liabilities	$2.882M	$2.882M	$10.56M
YoY Change	-72.7%	-72.7%	-37.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.553M		-$9.332M
YoY Change	-83.36%		-28.37%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.45M	$22.45M	-$9.331M
YoY Change
Total Liabilities & Shareholders Equity	$25.34M	$25.34M	$51.35M
YoY Change	-50.66%	-50.66%	-78.05%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$6.093M	$7.876M	$1.116M
YoY Change	446.16%	2.74%	-109.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.070M	-$1.945M	-$1.007M
YoY Change	6.27%	24.93%	4.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$29.20M	$29.08M	$184.2M
YoY Change	-84.15%	-84.19%	-179.29%
Cash From Investing Activities	$29.20M	$29.08M	$184.2M
YoY Change	-84.15%	-84.19%	-179.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$28.39M	-$28.39M
YoY Change		-115.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-27.56M	-26.52M	-183.5M
YoY Change	-84.99%	-85.55%	-178.31%
NET CHANGE
Cash From Operating Activities	-1.070M	-1.945M	-1.007M
Cash From Investing Activities	29.20M	29.08M	184.2M
Cash From Financing Activities	-27.56M	-26.52M	-183.5M
Net Change In Cash	574.7K	617.6K	-352.0K
YoY Change	-263.26%	-155.27%	-131.15%
FREE CASH FLOW
Cash From Operating Activities	-$1.070M	-$1.945M	-$1.007M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001851612
CY2023	bhac	Number Of Days Prior In Initial Business Combination NumberOfDaysPriorInInitialBusinessCombination	P2D
CY2023	bhac	Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod	P10D
CY2023Q3	us-gaap	Notes Payable Related Party Type Extensible Enumeration NotesPayableRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InvestorMember
CY2023	bhac	Stock Conversion Ratio StockConversionRatio	1
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40868
CY2023	dei	Entity Registrant Name EntityRegistrantName	FOCUS IMPACT BH3 ACQUISITION COMPANY
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2249068
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1345 Avenue of the Americas
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	33rd Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10105
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	213-0243
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	51900000
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2023Q4	us-gaap	Cash Cash	631337
CY2022Q4	us-gaap	Cash Cash	13715
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	138277
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11306
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0
CY2023Q4	us-gaap	Assets Current AssetsCurrent	780920
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13715
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	24554804
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	51340014
CY2023Q4	us-gaap	Assets Assets	25335724
CY2022Q4	us-gaap	Assets Assets	51353729
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	157789
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	0
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	283933
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	0
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	86230
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1074000
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2122940
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	300000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	346353
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0
CY2023Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	64750
CY2022Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	88006
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2882442
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3193993
CY2023Q4	bhac	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	0
CY2022Q4	bhac	Deferred Underwriting Fee Payable Noncurrent DeferredUnderwritingFeePayableNoncurrent	8050000
CY2023Q4	us-gaap	Liabilities Liabilities	2882442
CY2022Q4	us-gaap	Liabilities Liabilities	11243993
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	24005323
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	50125920
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1552615
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10016759
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1552041
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10016184
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25335724
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51353729
CY2023	us-gaap	Operating Expenses OperatingExpenses	1692413
CY2022	us-gaap	Operating Expenses OperatingExpenses	2210778
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1692413
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2210778
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	301
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	2296926
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3038631
CY2023	bhac	Waiver Of Deferred Offering Costs Liability WaiverOfDeferredOfferingCostsLiability	8050000
CY2022	bhac	Waiver Of Deferred Offering Costs Liability WaiverOfDeferredOfferingCostsLiability	0
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1048940
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6836233
CY2023	bhac	Change In Fair Value Of Note Payable ChangeInFairValueOfNotePayable	-87204
CY2022	bhac	Change In Fair Value Of Note Payable ChangeInFairValueOfNotePayable	0
CY2023	bhac	Non Redemption Agreements NonRedemptionAgreements	-1230000
CY2022	bhac	Non Redemption Agreements NonRedemptionAgreements	0
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	10078963
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	9874864
CY2023	bhac	Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability	8386550
CY2022	bhac	Income Loss From Continuing Operations Before Income Taxes Excluding The Impact Of Fin48 Liability IncomeLossFromContinuingOperationsBeforeIncomeTaxesExcludingTheImpactOfFIN48Liability	7664086
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	510293
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	683047
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7876257
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-13027247
CY2022	bhac	Redeemable Common Stock Accretion To Redemption Value RedeemableCommonStockAccretionToRedemptionValue	3969976
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10016184
CY2023	bhac	Redeemable Common Stock Accretion To Redemption Value RedeemableCommonStockAccretionToRedemptionValue	2272693
CY2023	bhac	Deemed Contribution By Former Sponsor DeemedContributionByFormerSponsor	1323661
CY2023	bhac	Contribution Non Redemption Agreements ContributionNonRedemptionAgreements	1230000
CY2023	bhac	Polar Share Subscription Agreement PolarShareSubscriptionAgreement	590851
CY2023	bhac	Excise Tax Payable ExciseTaxPayable	283933
CY2023	bhac	Stock Cancellation And Retirement During Period Value StockCancellationAndRetirementDuringPeriodValue	0
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7876257
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1552041
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7876257
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	2296926
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3038631
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1048940
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6836233
CY2023	bhac	Change In Fair Value Of Note Payable ChangeInFairValueOfNotePayable	-87204
CY2022	bhac	Change In Fair Value Of Note Payable ChangeInFairValueOfNotePayable	0
CY2023	bhac	Recovery Of Offering Costs Allocated To Warrants RecoveryOfOfferingCostsAllocatedToWarrants	8050000
CY2022	bhac	Recovery Of Offering Costs Allocated To Warrants RecoveryOfOfferingCostsAllocatedToWarrants	0
CY2023	bhac	Increase Decrease In Non Redemption Agreements IncreaseDecreaseInNonRedemptionAgreements	-1230000
CY2022	bhac	Increase Decrease In Non Redemption Agreements IncreaseDecreaseInNonRedemptionAgreements	0
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	11306
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-570994
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	157789
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5000
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-23256
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	88006
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	134293
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	683047
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1944885
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1556778
CY2023	bhac	Proceeds From Sale Of Marketable Securities In Trust Account ProceedsFromSaleOfMarketableSecuritiesInTrustAccount	0
CY2022	bhac	Proceeds From Sale Of Marketable Securities In Trust Account ProceedsFromSaleOfMarketableSecuritiesInTrustAccount	232527061
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	350881
CY2022	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	0
CY2023	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1039727
CY2022	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	0
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	748934935
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	700391261
CY2023	bhac	Proceeds From Cash Withdrawal From Trust Account In Connection With Redemptions ProceedsFromCashWithdrawalFromTrustAccountInConnectionWithRedemptions	28393290
CY2022	bhac	Proceeds From Cash Withdrawal From Trust Account In Connection With Redemptions ProceedsFromCashWithdrawalFromTrustAccountInConnectionWithRedemptions	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29082136
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	183983387
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	988402
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	300000
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	850000
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	812411
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	477152
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	28393290
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	183844056
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26519629
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-183544056
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	617622
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1117447
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13715
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1131162
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	631337
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13715
CY2023	bhac	Accretion For Ordinary Shares To Redemption Value AccretionForOrdinarySharesToRedemptionValue	2272693
CY2022	bhac	Accretion For Ordinary Shares To Redemption Value AccretionForOrdinarySharesToRedemptionValue	0
CY2023	bhac	Excise Tax Payable ExciseTaxPayable	283933
CY2022	bhac	Excise Tax Payable ExciseTaxPayable	0
CY2023	bhac	Conversion Of Class B Common Stock To Class A Common Stock ConversionOfClassBCommonStockToClassACommonStock	300
CY2022	bhac	Conversion Of Class B Common Stock To Class A Common Stock ConversionOfClassBCommonStockToClassACommonStock	0
CY2023	bhac	Noncash Or Part Noncash Deemed Contribution Forgiveness Of Convertible Promissory Note NoncashOrPartNoncashDeemedContributionForgivenessOfConvertiblePromissoryNote	988402
CY2022	bhac	Noncash Or Part Noncash Deemed Contribution Forgiveness Of Convertible Promissory Note NoncashOrPartNoncashDeemedContributionForgivenessOfConvertiblePromissoryNote	0
CY2023	bhac	Noncash Or Part Noncash Deemed Contribution Forgiveness Of Promissory Notes NoncashOrPartNoncashDeemedContributionForgivenessOfPromissoryNotes	335259
CY2022	bhac	Noncash Or Part Noncash Deemed Contribution Forgiveness Of Promissory Notes NoncashOrPartNoncashDeemedContributionForgivenessOfPromissoryNotes	0
CY2023	bhac	Cancellation And Retirement Of Common Stock CancellationAndRetirementOfCommonStock	1
CY2022	bhac	Cancellation And Retirement Of Common Stock CancellationAndRetirementOfCommonStock	0
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	376000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
CY2023Q4	bhac	Interest On Trust Account To Be Held To Pay Dissolution Expenses InterestOnTrustAccountToBeHeldToPayDissolutionExpenses	100000
CY2023Q4	bhac	Interest On Trust Account To Be Held To Pay Dissolution Expenses InterestOnTrustAccountToBeHeldToPayDissolutionExpenses	100000
CY2023	bhac	Period Of Extension To Business Combination PeriodOfExtensionToBusinessCombination	P30D
CY2023Q4	bhac	Number Of Shares Opted For Non Redemption NumberOfSharesOptedForNonRedemption	1946794
CY2023Q4	bhac	Number Of Shares Transferred By New Sponsor To Non Redemption Holders NumberOfSharesTransferredByNewSponsorToNonRedemptionHolders	389359
CY2023Q4	bhac	Stock Conversion Ratio StockConversionRatio	1
CY2023Q4	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2700563
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2750000
CY2023Q4	us-gaap	Cash Cash	631337
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	24554804
CY2023Q4	bhac	Working Capital Deficit WorkingCapitalDeficit	2101522
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	850000
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	88006
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3193993
CY2022Q4	us-gaap	Liabilities Liabilities	11243993
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10016759
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10016184
CY2022	us-gaap	Operating Expenses OperatingExpenses	2210778
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2210778
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7664086
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	683047
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10016759
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10016184
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	88006
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	683047
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align: justify; margin-right: 7.05pt; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</div>
CY2023Q4	us-gaap	Cash Cash	631337
CY2022Q4	us-gaap	Cash Cash	13715
CY2022Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align: justify; margin-right: 7.05pt; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Concentration of Credit Risk</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts or investment accounts in a financial institution, which at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.</div>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2023Q4	us-gaap	Notes Payable NotesPayable	64749
CY2023Q4	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	335259
CY2023	bhac	Holding Period For Transfer Assignment Or Sale Of Founder Shares HoldingPeriodForTransferAssignmentOrSaleOfFounderShares	P1Y
CY2023Q4	us-gaap	Share Price SharePrice	12
CY2023	bhac	Threshold Trading Days ThresholdTradingDays	P20D
CY2023	bhac	Threshold Consecutive Trading Days ThresholdConsecutiveTradingDays	P30D
CY2023	bhac	Period After Initial Business Combination PeriodAfterInitialBusinessCombination	P150D
CY2023Q4	us-gaap	Share Price SharePrice	3.13
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	156500
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	50000
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000000
CY2023Q4	bhac	Excess Of Fair Value To Be Received ExcessOfFairValueToBeReceived	156300
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	988402
CY2023Q4	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	335259
CY2023Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	64750
CY2022Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	88006
CY2023	bhac	Fair Value Of Non Redemption Agreements FairValueOfNonRedemptionAgreements	1230000
CY2023Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	1200000
CY2023	bhac	Capital Contribution Repaid Period CapitalContributionRepaidPeriod	P5D
CY2023	bhac	Common Stock Issued For Each Dollar Of Capital Contribution CommonStockIssuedForEachDollarOfCapitalContribution	1
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	850000
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	850000
CY2023Q4	bhac	Value Of Shares Issuable As Of The Execution Date Of Cma Contracts ValueOfSharesIssuableAsOfTheExecutionDateOfCMAContracts	312600
CY2023Q4	bhac	Additional Capital Market Advisor Liability Current AdditionalCapitalMarketAdvisorLiabilityCurrent	3500000
CY2023Q4	bhac	Percentage Of Deferred Cma Fees PercentageOfDeferredCMAFees	0.04
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2312029
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5012592
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5012592
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2312029
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	283933
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7876257
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6981039
CY2023	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2556626
CY2022	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	3969976
CY2023	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	5319631
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	3011063
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.1
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	510293
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	683047
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	bhac	Stock Conversion As Converted Percentage StockConversionAsConvertedPercentage	0.20
CY2023	bhac	Period To Exercise Warrants After Business Combination PeriodToExerciseWarrantsAfterBusinessCombination	P30D
CY2023	bhac	Period To Exercise Warrants After Closing Of Initial Public Offering PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering	P12M
CY2023	bhac	Period For Registration Statement To Become Effective PeriodForRegistrationStatementToBecomeEffective	P60D
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023	bhac	Period To File Registration Statement After Initial Business Combination PeriodToFileRegistrationStatementAfterInitialBusinessCombination	P20D
CY2023Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P0Y6M29D
CY2023	bhac	Number Of Demands That Can Be Made NumberOfDemandsThatCanBeMade	3
CY2023	bhac	Underwriting Fee Discount Percentage UnderwritingFeeDiscountPercentage	0.02
CY2023	bhac	Underwriting Discount UnderwritingDiscount	4600000
CY2023	bhac	Underwriter Deferred Fee Discount Percentage UnderwriterDeferredFeeDiscountPercentage	0.035
CY2023Q4	bhac	Deferred Underwriting Commissions DeferredUnderwritingCommissions	8100000
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	138277
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	86230
CY2023Q4	bhac	Deferred Tax Asset Startup Costs DeferredTaxAssetStartupCosts	955617
CY2022Q4	bhac	Deferred Tax Asset Startup Costs DeferredTaxAssetStartupCosts	596817
CY2023Q4	bhac	Deferred Tax Assets Unrealized Gain Loss DeferredTaxAssetsUnrealizedGainLoss	-3860
CY2022Q4	bhac	Deferred Tax Assets Unrealized Gain Loss DeferredTaxAssetsUnrealizedGainLoss	3860
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	951757
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	600677
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	951757
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	600677
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	419543
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	565795
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	90749
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	117066
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2023	bhac	Income Tax Expense Benefit Excluding Impact Of Fin48 Liability IncomeTaxExpenseBenefitExcludingImpactOfFIN48Liability	510292
CY2022	bhac	Income Tax Expense Benefit Excluding Impact Of Fin48 Liability IncomeTaxExpenseBenefitExcludingImpactOfFIN48Liability	682861
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	351290
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	184278
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.044
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.044
CY2023	bhac	Effective Income Tax Rate Reconciliation Unrealized Gain Loss Percent EffectiveIncomeTaxRateReconciliationUnrealizedGainLossPercent	0.008
CY2022	bhac	Effective Income Tax Rate Reconciliation Unrealized Gain Loss Percent EffectiveIncomeTaxRateReconciliationUnrealizedGainLossPercent	-0.006
CY2023	bhac	Effective Income Tax Rate Reconciliation Recovery Of Offering Costs Attributable To Warrants EffectiveIncomeTaxRateReconciliationRecoveryOfOfferingCostsAttributableToWarrants	-0.246
CY2022	bhac	Effective Income Tax Rate Reconciliation Recovery Of Offering Costs Attributable To Warrants EffectiveIncomeTaxRateReconciliationRecoveryOfOfferingCostsAttributableToWarrants	0
CY2023	bhac	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeWarrantLiabilities	-0.032
CY2022	bhac	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeWarrantLiabilities	-0.226
CY2023	bhac	Effective Income Tax Rate Reconciliation Borrowings On Note Payable Percent EffectiveIncomeTaxRateReconciliationBorrowingsOnNotePayablePercent	0.003
CY2022	bhac	Effective Income Tax Rate Reconciliation Borrowings On Note Payable Percent EffectiveIncomeTaxRateReconciliationBorrowingsOnNotePayablePercent	0
CY2023	bhac	Effective Income Tax Rate Reconciliation Non Redemption Agreements EffectiveIncomeTaxRateReconciliationNonRedemptionAgreements	0.037
CY2022	bhac	Effective Income Tax Rate Reconciliation Non Redemption Agreements EffectiveIncomeTaxRateReconciliationNonRedemptionAgreements	0
CY2023	bhac	Effective Income Tax Rate Reconciliation State Taxes Percent EffectiveIncomeTaxRateReconciliationStateTaxesPercent	0
CY2022	bhac	Effective Income Tax Rate Reconciliation State Taxes Percent EffectiveIncomeTaxRateReconciliationStateTaxesPercent	-0.002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.034
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.069
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.061
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.089
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	358800
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	596817
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	596817
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	596817
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	358800
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	955617

Files In Submission

Name	View Source	Status
0001140361-24-021328-index-headers.html	Edgar Link	pending
0001140361-24-021328-index.html	Edgar Link	pending
0001140361-24-021328.txt	Edgar Link	pending
0001140361-24-021328-xbrl.zip	Edgar Link	pending
bhac-20231231.xsd	Edgar Link	pending
ef20023732_10k.htm	Edgar Link	pending
ef20023732_ex10-12.htm	Edgar Link	pending
ef20023732_ex21-1.htm	Edgar Link	pending
ef20023732_ex31-1.htm	Edgar Link	pending
ef20023732_ex31-2.htm	Edgar Link	pending
ef20023732_ex32-1.htm	Edgar Link	pending
ef20023732_ex32-2.htm	Edgar Link	pending
ef20023732_ex4-5.htm	Edgar Link	pending
ef20023732_ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
bhac-20231231_def.xml	Edgar Link	unprocessable
bhac-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ef20023732_10k_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bhac-20231231_cal.xml	Edgar Link	unprocessable
bhac-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHAC
Focus Impact BH3 Acquisition Co Stock $bhac

2023 Q4 Form 10-K Financial Statement

#000114036124021328 Filed on April 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHAC Focus Impact BH3 Acquisition Co Stock $bhac

2023 Q4 Form 10-K Financial Statement

#000114036124021328 Filed on April 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHAC
Focus Impact BH3 Acquisition Co Stock $bhac